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genes between extremes of placental
efficiency in maternal line gilts on day 95
of gestation
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Matthew E. Wilson6 and Tiffany A. Wilmoth1*

Abstract
Background: Placental efficiency (PE) describes the relationship between placental and fetal weights (fetal wt/placental
wt). Within litters, PE can vary drastically, resulting in similarly sized pigs associated with differently sized placentas, up to a
25% weight difference. However, the mechanisms enabling the smaller placenta to grow a comparable littermate are
unknown. To elucidate potential mechanisms, morphological measurements and gene expression profiles in placental
and associated endometrial tissues of high PE and low PE feto-placental units were compared. Tissue samples were
obtained from eight maternal line gilts during gestational day 95 ovario-hysterectomies. RNA was extracted from tissues
of feto-placental units with the highest and lowest PE in each litter and sequenced.
Results: Morphological measurements, except placental weight, were not different (P > 0.05) between high and low PE.
No DEG were identified in the endometrium and 214 DEG were identified in the placenta (FDR < 0.1), of which 48% were
upregulated and 52% were downregulated. Gene ontology (GO) analysis revealed that a large percentage of DEG were
involved in catalytic activity, binding, transporter activity, metabolism, biological regulation, and localization. Four GO
terms were enriched in the upregulated genes and no terms were enriched in the downregulated genes (FDR < 0.05).
Eight statistically significant correlations (P < 0.05) were identified between the morphological measurements and DEG.
Conclusion: Morphological measures between high and low PE verified comparisons were of similarly sized pigs grown
on different sized placentas, and indicated that any negative effects of a reduced placental size on fetal growth were not
evident by day 95. The identification of DEG in the placenta, but absence of DEG in the endometrium confirmed that the
placenta responds to the fetus. The GO analyses provided evidence that extremes of PE are differentially regulated,
affecting components of placental transport capacity like nutrient transport and blood flow. However, alternative GO
terms were identified, indicating the complexity of the relationship between placental and fetal weights. These findings
support the use of PE as a marker of placental function and provide novel insight into the genetic control of PE, but
further research is required to make PE production applicable.
Keywords: Endometrium, Fetal weight, Gene expression, Pigs, Placenta, Placental efficiency, Placental weight
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Background
Placental efficiency (PE), quantified by the ratio of fetal
or birth weight to placental weight, is commonly used as
a marker of placental function in humans and animals.
The ratio reflects grams of fetus produced per gram of
placenta [1]. In general, it is assumed that high PE values
associated with averaged sized fetuses represent placentas with a greater nutrient transport capacity, while low
PE values associated with growth restricted fetuses
represent placentas with a reduced nutrient transport
capacity or a failure to adapt.
In humans, PE (birth wt/placental wt) is reduced during pregnancy complications like fetal growth restriction,
small for gestational age, gestational diabetes mellitus,
and pre-eclampsia [2]. Therefore, the ratio is often used
to predict abnormal fetal growth, and consequently
health later in life. However, whether alterations in PE
truly reflect adaptations in human placental nutrient
transport capacity remains unclear. The most compelling
evidence for an association between the two is in mice,
with conflicting reports in humans [2]. Coan and others
[3] evaluated placental nutrient transport capacity in
mice with natural variations in placental size to determine if the smallest placenta in a litter of appropriately
grown fetuses was the most efficient. The authors reported near term fetuses with lighter placentas were of
comparable weight to fetuses with heavier placentas, and
thus, PE was greater in the lightest placentas. Additionally, expression of Slc2a1, a glucose transporter gene,
and Slc38a2, an amino acid transporter gene, were upregulated in the lightest placentas, providing evidence
that high PE placentas adapt to meet the nutrient demands of the growing fetus.
Natural variations in PE are also apparent in pigs, a
litter bearing species. These variations are not only between, but also within, breeds and even within litters
[4]. Within a litter, PE can vary drastically, resulting in
similarly sized pigs grown on very different placentas,
with up to a 25% weight difference [5]. High PE placenta are smaller in size than low PE placenta, thus,
high PE placentas occupy less space in the uterus and
still grow an averaged sized littermate. While the use of
PE as a selection tool to increase litter size has been debated [6], PE may provide an opportunity to optimize
reproductive performance. The average litter size of
U.S. production breeds has continued to increase over
time and is currently 10.6 [7], but ovulation rates [8]
and teat numbers [9] indicate the maximum has not
been reached. At the same time, increases in litter size
have resulted in lower birth weights, less uniform litters, and greater preweaning mortalities, minimizing
the benefits of producing more pigs per litter. Increasing PE in these larger litters may normalize birth
weights and, as a result, increase preweaning survival.
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In fact, Vernunft and others [10] reported on the relationship between placental size and measures of reproductive performance in modern Landrace sows. The
authors concluded sows with larger litters and shorter
placentas can rescue placental function. However, the
compensatory mechanisms driving the growth of an
adequately sized fetus on a smaller placenta are still
being investigated.
In comparisons of breeds differing in PE, the increased
efficiency of high PE placentas was attributed to greater
vascularity [11]. Yet, variations in PE within production
breed litters on day 90 of gestation could not be attributed to differences in vascular density (VD) despite increased expression of vascular endothelial growth factor
and associated receptors in high PE placentas [12]. Recently, Krombeen and others [5] reported placental VD
was positively related to PE on day 110 of gestation in
maternal line gilts. The results of Vonnahme and Ford
[12] in conjunction with Krombeen and others [5] suggest morphological adaptations, like increases in VD,
may occur later in gestation (day 90 to term) to maintain
fetal growth when placental size is reduced.
Krombeen and others [5] also investigated the relationship between PE and seven genes encoding glucose, amino acid, or fatty acid transporters in the
placenta and adjacent endometrium of maternal line
gilts on day 70, 90, and 110 of gestation. Based on
conditional effects plots, variations in PE on day 70
of gestation were related to alterations in amino acid
transporter expression (SLC7A7, SLC7A1, SLC3A1) in
the placenta and endometrium. On day 90 of gestation, PE was positively related to placental expression
of a glucose transporter (SLC2A3) and negatively related to endometrial expression of two cationic amino
acid transporters (SLC7A1 and SLC7A2) and a very
long chain fatty acid transporter (SLC27A1). Near
term (day 110), PE was negatively related to two
amino acid transporters (SLC7A7 and SLC7A1) and a
glucose transporter (SLC2A3). The results of Krombeen and others [5] agree with those of Coan and
others [3] and supports the use of PE as a marker of
placental function.
Although the study by Krombeen and others [5]
provides evidence for an association between PE and
placental nutrient transport capacity, only seven genes
encoding nutrient transporters were investigated.
Zhou and others [13] detected 226 and 577 differentially expressed genes on gestational days 75 and 90,
respectively, between two breeds with differing PE.
Similarly, Kwon and others [14] identified 588 differentially expressed genes in placentas from larger litter
sizes compared to smaller litter sizes. Therefore, it is
likely the compensatory mechanisms enabling comparable fetal growth despite reductions in placental
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size (high PE) are controlled by many genes and the
interactions of those genes, as seen in Zhou and
others [13] and Kwon and others [14].
However, the global expression of genes in the placenta
of the high and low PE feto-placental units within a litter
has not been investigated. The hypothesis of this work
was that extremes of PE would be associated with differentially expressed genes (DEG) that affect fetal growth via
gene products that promote growth, vascularity, and/or
nutrient transport. The main objective was to determine
and understand the role of gene expression profiles in placental and associated endometrial tissues of high PE and
low PE feto-placental units. A secondary objective was to
compare fetal and utero-placental measurements of high
PE and low PE units.

Results
Fetal and utero-placental measurements

Mean litter size was 10.75 and ranged from 5 to 15. There
was no association between litter size and PE (r = − 0.04, P
= 0.72). Table 1 contains least square means ± SE of fetal
and placental measurements. Mean placental weight was
lower in the high PE group compared to the low PE group
(P = 0.0002, Fig. 1), but mean fetal weight was not different
between high and low PE (P = 0.5914, Fig. 1). While the effect of sex was not significant for placental weight or
fetal weight, there was a significant interaction between
PE and sex for placental weight (P = 0.0479, Table 1).
Males had lower weight placentas than females in the
high PE group, but the opposite was true in the low PE
group (Fig. 2).
Mean implantation site length (ISL), crown-rump
length (CRL), girth, heart weight, liver weight, brain
weight, and semitendinosus (ST) weight were not significantly different between the high PE group and the low

PE group (P = 0.8208, 0.4338, 0.7310, 0.2071, 0.1925,
0.8254, and 0.6886, respectively). There were also no
significant differences in mean placental or endometrial vascular density (VD) between high PE and low
PE (P = 0.2689, 0.5463, respectively). For these variables, there was no significant effect of sex and there
were no significant interactions between PE and sex.
Differential gene expression and gene ontology

The number of genes expressed in the placenta and
endometrium was 20,280. In total, 214 DEG (FDR <
0.1) were identified in the placenta (Fig. 3a) and 0
DEG (FDR < 0.1) were identified in the endometrium
(Fig. 3b). Of the DEG in the placenta, 103 genes were
upregulated (33 log fold change (log2FC) ≥ 1; 70 0 <
log2FC < 1.0) and 111 genes were downregulated (49
log2FC ≤ − 1.0; 62 -1.0 < log2FC < 0). Table 2 lists a
subset of the candidate genes in high PE compared to
low PE placentas.
The results of the functional classification analysis are
presented in Fig. 4, which illustrates percentages of upregulated compared to downregulated genes designated
by MF (Fig. 4a) or BP (Fig. 4b) gene ontology (GO)
terms for high PE compared to low PE. The MF of catalytic activity, binding, and transporter activity had the
greatest representation. More catalytic activity genes
(39% vs 25.5%) and transporter activity genes (14% vs
10%) were upregulated than downregulated, while the
opposite was true for binding activity genes (29% vs
37%). Additionally, a greater percentage of downregulated genes compared to upregulated genes were
molecular function regulators or had transcription regulator activity (both 2% vs 10%). The BP terms with the
greatest representation were metabolic process, biological regulation, and localization. Upregulated genes

Table 1 Least square means ± SE of fetal and utero-placental measurements of high PE and low PE units
Measurementb

P-valuea

Placental efficiency
Low

High

PE

Sex

Placental wt, g

322.21 ± 24.14

172.37 ± 25.39

0.0002*

0.7257

PE × Sex
0.0479*

Fetal wt, g

831.28 ± 99.36

782.04 ± 106.59

0.5914

0.3647

0.4386

ISL, cm

21.08 ± 3.05

22.19 ± 3.60

0.8208

0.6657

0.9710

CRL, cm

25.88 ± 1.35

25.02 ± 1.42

0.4338

0.2303

0.7022

Girth, cm

17.58 ± 1.34

18.27 ± 2.02

0.7310

0.9900

0.4043

Heart wt, g

7.63 ± 1.06

5.92 ± 1.19

0.2071

0.7930

0.3736

Liver wt, g

21.97 ± 3.14

17.86 ± 3.38

0.1925

0.4927

0.5075

Brain wt, g

19.95 ± 0.72

19.73 ± 0.83

0.8254

0.5937

0.7535

ST wt, g

1.60 ± 0.22

1.50 ± 0.23

0.6886

0.6552

0.8463

Placental VD, %

8.19 ± 1.35

5.74 ± 1.56

0.2689

0.3511

0.4941

Endometrial VD, %

6.15 ± 1.73

7.48 ± 1.96

0.5463

0.8872

0.4179

Effect of placental efficiency (PE), effect of sex (Sex), effect of placental efficiency by sex interaction (PE × Sex). bISL Implantation site length, CRL crown-rump length, ST
semitendinosus, VD vascular density. (*) asterisk indicates P < 0.05
a
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Fig. 1 Mean placental and fetal weight. Mean placental weight and fetal
weight of low PE and high PE feto-placental units on day 95 of gestation
in pigs. Data presented as means ± SD. Asterisk (*) indicates P < 0.05

were involved in metabolic processes (27% vs 17%) and
localization (15% vs 11%) more often than downregulated genes, while downregulated genes were involved in
biological regulation more often than upregulated genes
(21% vs 27%). Also, the terms developmental process
(0% vs 13%) and biological adhesion (3 vs 9%) were associated with more downregulated than upregulated genes.
Table 3 contains the results of the GO enrichment analysis
performed on the DEG in high PE compared low PE placentas. Four terms were significantly (FDR < 0.05) enriched in
the upregulated genes and no terms were significantly
enriched in the downregulated genes. The MF terms sodium-dependent multivitamin transmembrane transporter

Fig. 3 Gene Expression. a Volcano plot of DEG in high PE compared to
low PE placental tissue on day 95 of gestation in pigs. Black dots indicate
FDR > 0.10 or |log2FC| < 1. Non-black dots indicate DEG (FDR < 0.10,
|log2FC| ≥ 1). Dot colors indicate log2FC range. b Volcano plot of DEG in
high PE compared to low PE endometrial tissues on day 95 of gestation
in pigs. Black dots indicate FDR > 0.10 or |log2FC| < 1

activity and nucleobase transmembrane transporter activity,
the BP term nucleobase transport, and the cellular component term extracellular exosome were enriched.

Fig. 2 Mean placental weight by sex. Mean placental weight in low PE
and high PE male and female feto-placental units on day 95 of
gestation. Data presented as means ± SD

Fetal/utero-placental measurements and differentially
expressed genes

Eight significant correlations (P < 0.05) were identified
between fetal and utero-placental measurements, and
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Table 2 Candidate genes in high PE compared to low PE placentas
Gene Symbol

Gene Name

log2FCa

FDR P-value2

Gene Ontology (MF; BP)b

SAA2

Serum Amyloid A2

4.89

0.00002

binding, molecular
transducer activity;
locomotion

SPHKAP

Sphingosine Kinase Type 1

2.88

0.00388

binding

DKK1

Dickkopf-1

2.80

0.00876

binding, molecular
transducer activity,
molecular function
regulator; biological
regulation

CYP4F22

Cytochrome P450 Family 4
Subfamily F Member 22

2.44

0.05077

catalytic activity;
metabolic process

FBP2

Fructose-1, 6-Bisphosphatase
Isoenzyme 2

2.42

0.08290

catalytic activity;
metabolic process

PCDHB1

Protocadherin Beta-1
Isoform X2

2.42

0.00302

;biological adhesion

SLC45A3

Solute Carrier Family 45
Member 3

1.89

0.07267

transporter activity,
metabolic process

ASIC1

Acid Sensing Ion Channel 1
Isoform X2

1.81

0.05118

transporter activity;
biological regulation,
localization, multicellular
organismal process

CELA1

Chymotrypsin-like Elastase
Family Member 1

1.55

0.04841

catalytic activity

LEP

Leptin

1.01

0.05194

growth factor activity,
hormone activityc

ATP13A3

Probable Cation-Transporting
ATPase 13A3

0.82

0.06425

; biological regulation

SLC4A7

Solute Carrier Family 4
Member 7

0.77

0.04207

transporter activity

CTSH

Pro-cathepsin H

0.71

0.07854

; positive regulation
of angiogenesisc

SLC52A3

Solute Carrier Family 52
Member 3

0.68

0.01438

molecular transducer activity;
biological regulation

SLC23A2

Solute Carrier Family 23
Member 2

0.59

0.06802

transporter activity; localization

AGR2

Anterior Gradient Protein
2 Homolog

−2.99

0.00045

; biological regulation,
cellular process

EMB

Embigin

−2.06

0.01288

binding; biological
adhesion, cellular process

STEAP1

Six-Transmembrane Epithelial
Antigen of Prostate 1

−1.98

0.05194

catalytic activity; localization

SARDH

Sarcosine Dehydrogenase

−1.89

0.02504

catalytic activity; metabolic
process

STEAP2

Six Transmembrane Epithelial
Antigen of the Prostate 2

−1.72

0.07267

catalytic activity; localization

MRP4

Multidrug Resistance-Associated
Protein 4-like

−1.61

0.07267

transporter activity

KCNJ2

Potassium Channel, Inwardly
Rectifying Subfamily J, Member 2

−1.31

0.00875

transporter activity

ANGPT1

Angiopoietin-1

−0.75

0.07031

binding; biological regulation,
biological adhesion

a
log2FC log2 fold change. 2FDR P-value False discovery rate adjusted P-value, level of significance P < 0.10. bMF Molecular function, BP biological process. Genes
above dotted line were among ten most upregulated or downregulated. cNo hits for Panther GO slim terms, specific GO terms used instead
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Molecular Function
Molecular Function Regulator
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Transcription Regulator Activity
Structural Molecule Activity
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0
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Gene hit against total No. function hits,
Downregulated
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GO Term

B
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Cellular Process
Localization
Biological Regulation
Metabolic Process

0
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Gene hit against total No. function hits,
Downregulated
Upregulated
Fig. 4 Gene Ontology Functional Classification Analysis. a Molecular function GO terms of DEG in high PE compared to low PE placentas on day
95 of gestation in pigs. b Biological Process GO terms of DEG in high PE compared to low PE placentas on day 95 of gestation in pigs. Subfigures
included 160 of the 214 DEG

the 214 DEG in high PE compared to low PE placentas
(Table 4), of which 5 were placental weight and 3 were
PE correlations. Placental weight was positively correlated
with GRINL1A complex locus 1 (GCOM1, r = 0.82, P =
0.0214), gene19656 (LOC100739517, r = 0.78, P = 0.0257),
TOX high mobility group box family member 3 (TOX3, r =
0.77, P = 0.0257), and ATP-binding cassette sub-family G
member 2 (ABCG2, r = 0.76, P = 0.0257), but negatively
correlated with ras-related protein rab-6B (RAB6B, r = −
0.76, P = 0.0257). Placental efficiency was positively correlated
with gene12188 (LOC100156118, r = 0.81, P = 0.0214), transmembrane protein 199 (TMEM199, r = 0.81, P = 0.0214),
and proto-cadherin beta 1 (PCDHB1, r = 0.76, P = 0.0428).

Discussion
Fetal and utero-placental measurements

Placental weight was lower in the high PE group compared to the low PE group, but fetal weight was not different between high and low PE. These results agree
with Krombeen and others [5] and confirm high PE placentas are smaller than low PE placentas, yet each grow
a littermate of comparable size. There was a significant
interaction between PE and sex for placental weight,
which to the authors’ knowledge has not previously been
reported in PE studies.
The lack of a difference in ISL between high PE and low
PE was unexpected as the basis for high PE is a smaller

Krombeen et al. BMC Genomics

(2019) 20:254

Page 7 of 15

Table 3 Gene Ontology Enrichment Analysis
Ontologya

Category

GO Term

No. DEG in Category

No. in Category

FDR P-value

Gene Symbolb

MF

GO:0008523

Sodium-dependent
multivitamin transmembrane
transporter activity

2

3

0.0486

SLC23A2, LOC102159690

MF

GO:0015205

Nucleobase transmembrane
transporter activity

2

3

0.0486

SLC23A2, LOC102159690

BP

GO:0015851

Nucleobase transport

2

3

0.0486

SLC23A2, LOC102159690

CC

GO:0070062

Extracellular exosome

20

2283

0.0486

TXN, TXNDC8, MGST3,
CADM4, PI16, CTSH,
ABCB1, FBP2, RPL15,
ITIH3, PDHB, PEBP1,
PPA1, GCA, HSPE1,
SPHKAP, EFHD1,
ENTPD6, AK2, GLA

Significantly enriched GO terms of upregulated genes in high PE compared to low PE placentas on day 95 of gestation in pigs. Level of significance P < 0.05. aMF Molecular
function, BP Biological process, CC Cellular component, GO Gene ontology, DEG Differentially expressed genes, FDR P-value False discovery rate adjusted P-value, bSLC23A2
Solute carrier family 23 member 2, LOC102159690 solute carrier family 23 member 2-like, TXN Thioredoxin, TXNDC8 Thioredoxin domain-containing protein 8, MGST3
Microsomal glutathione S-transferase 3, CADM4 Cell adhesion molecule 4, PI16 Peptidase inhibitor 16 precursor, CTSH Pro-cathepsin H, ABCB1 ATP-binding cassette subfamily
B member 1 isoform X2, FBP2 Fructose-1, 6-biphosphatase isoenzyme 2, RPL15 Ribosomal protein L15, ITIH3 Inter-alpha-trypsin inhibitor heavy chain H3, PDHB Pyruvate
dehydrogenase E1 component subunit beta, PEBP1 Phosphatidylethanolamine-binding protein 1, PPA1 Inorganic pyrophosphatase, GCA Grancalcin, HSPE1 10 KDa heat
shock protein, mitochondrial, SPHKAP A-kinase anchoring protein, EFHD1 EF-hand domain-containing protein D1 isoform X2, ENTPD6 Ectonucleoside triphosphate
diphosphohydrolase 6, AK2 Adenylate kinase 2, GLA Alpha-galactosidase A

but more efficient placenta that occupies less room within
the uterus [4, 11]. Furthermore, a previous study reported
high PE ISL were shorter than low PE ISL [12]. The conflicting results suggest ISL differs when PE is used as a selection tool as opposed to observing natural variations in
PE. Alternatively, the folded placental trophoblast-endometrial epithelial bilayer width may be greater in
feto-placental units with reduced placental size and comparable fetal growth (high PE). Vallet and Freking [15],

reported greater fold widths were associated with the
smallest pig fetuses in a litter and may increase PE via a
larger surface area for exchange between the maternal and
fetal circulations.
In addition to ISL, CRL, girth, heart weight, liver
weight, brain weight, and ST weight were not significantly different between the high PE group and the low
PE group. Crown-rump length and girth are highly correlated to fetal age [16] and weight [17, 18], and can be

Table 4 Significant correlations between fetal/utero-placental measurements and DEG in high PE compared to low PE placentas
Correlation Dataa

DEG Datab

Measurement* Gene Correlation FDR P-value Gene Symbol

Protein

Molecular Function

log FC FDR P-value

Myocardial Zonula
Adherens Protein

N/A

−0.43

0.0769

LOC100156118 N/A

N/A

0.63

0.0484

0.0214

TMEM199

N/A

0.29

0.0421

0.78

0.0257

LOC100739517 ATP-Binding Cassette
Sub-Family G Member 2

N/A

−0.61

0.0144

PW*gene13353

0.77

0.0257

TOX3

TOX High Mobility
Group Box Family
Member 3

Chromatin binding,
Phosphoprotein binding,
Protein homodimerization
activity, Estrogen response
element binding

−1.41

0.0183

PW*gene19659

0.76

0.0257

ABCG2

ATP-Binding Cassette
Sub-Family G Member 2

ATP binding, ATPase activity
−0.77
coupled to transmembrane
movement of substance,
Cholesterol transporter activity

0.0039

PE*gene6367

0.76

0.0428

PCDHB1

Protocadherin Beta-1
Isoform X2

Calcium ion binding

2.42

0.0030

PW*gene26368

−0.76

0.0257

RAB6B

Ras-Related Protein Rab-6B GTP binding, GTPase activity,
Myosin V binding

0.86

0.0084

PW*gene1223

0.82

0.0214

GCOM1

PE*gene12188

0.81

0.0214

PE*gene24847

0.81

PW*gene19656

Transmembrane
Protein 199

a
PW Placental weight, PE placental efficiency, FDR P-value false discovery rate adjusted P-value, level of significance P < 0.05. bDEG Differentially expressed genes,
N/A not available, log2FC log2 fold change, FDR P-value false discovery rate adjusted P-value, level of significance P < 0.10
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used to predict neonatal survival [19] and post-natal
growth performance [20]. Considering these fetal measurements did not differ based on PE, the survival and
postnatal growth performance of pigs grown on high PE
placentas should not be negatively affected. Moreover,
the absence of significant differences in fetal organ and
tissue weights supports data from Krombeen and others
[5], indicating any negative effects of a reduced placental
size on fetal growth are not evident by term.
Placental VD and endometrial VD were also not significantly different between high PE and low PE. High
PE in more prolific breeds has been attributed to increased placental VD during late gestation [11]; however,
the role VD plays in extremes of PE within production
breeds is less clear. Vonnahme and Ford [12] reported
there was no additional increase in placental or endometrial VD to account for the increased efficiency of
high PE placentas on day 90 of gestation in Yorkshires,
despite increased expression of a vascular growth factor
and its associated receptors. Conversely, Krombeen and
others [5] identified a positive relationship between placental VD and PE on day 110 of gestation in maternal
line gilts. It is conceivable that increased vascular permeability or reduced placental-endometrial intercapillary
distance contribute to high PE, as suggested by Vonnahme and Ford [12], and/or changes in VD occur after
day 90, as suggested by Krombeen and others [5].
Differential gene expression and gene ontology

A total of 214 DEG were identified in the placenta
and 0 DEG were identified in the endometrium. Since
the placenta is conceptus derived, it is not surprising
that a greater number of genes would be differentially
expressed in the placenta than in the endometrium,
which is maternal tissue. Of the genes expressed in
the placenta, only 214 were differentially expressed or
1.06% of the transcriptome. The small percentage of
DEG identified in this study could be attributed to
the comparison of two naturally occurring states as
opposed to two treatment groups, the gestational day
evaluated, and/or the expression level measured.
Nonetheless, the functional classification analysis performed on the DEG in high PE compared to low PE placentas identified molecular functions (MF) and biological
processes (BP) associated with the phenotype. The MF of
catalytic activity, binding, and transporter activity had the
greatest representation. Catalytic activity was a MF of
more upregulated than downregulated genes.
Upregulated candidate genes with catalytic activity included cytochrome P450 family 4 subfamily F member
22 (CYP4F22), fructose-1, 6-bisphosphatase isoenzyme 2
(FBP2), and chymotrypsin-like elastase family member 1
(CELA1). The catalytic activity of the products of
CYP4F22, recently identified as an ultra-long chain fatty
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acid omega hydroxylase [21], and FBP2, encoding the
gluconeogenic enzyme fructose-1,-6,biphosphatase-2
[22], suggests the metabolic state of high PE and low PE
placentas differs. The gene CELA1 encodes for an enzyme that degrades the protein elastin, a component of
the vascular matrix. Data in mice indicate there is a
positive association between CELA1 and angiogenesis
[23, 24]. While the catalytic activity of CELA1 may have
a role in vascularity, no differences in VD were detected
between high PE and low PE placentas.
Catalytic activity was also a function of downregulated
genes; six transmembrane epithelial antigen of prostate 1
(STEAP1), six transmembrane epithelial antigen prostate
2 (STEAP2), and sarcosine dehydrogenase (SARDH)
were candidate genes with catalytic activity. The STEAP
family of proteins function as metal reductases, enabling
the transport of iron and copper across the plasma
membrane, and superoxide synthases, generating superoxide [25, 26]. The gene SARDH encodes for a mitochondrial enzyme that catalyzes the conversion of sarcosine to
glycine, a major amino acid involved in an array of BP
[27]. The downregulation of these genes in high PE compared to low PE suggests metabolism differs by PE.
The MF GO term with the second greatest representation in the DEG was binding, with fewer upregulated
than downregulated genes involved in binding. Serum
amyloid A2 (SAA2), sphingosine kinase type 1 interacting protein (SPHKAP), and dickkopf-1 (DKK1), were the
three most upregulated genes in high PE compared to
low PE placentas and shared the MF of binding. These
genes encode a major acute phase protein involved in
the innate immune response [28], an A-kinase anchoring
protein involved in second messenger intracellular signaling [29], and a glycoprotein that is an inhibitor of the
Wnt signaling pathway [30], respectively. In general, it
appears the binding activity of these gene products is
relevant to cell signaling pathways. While the role of
these genes products within the placenta requires further
investigation, SAA2 and DKK1 have been implemented
in lipid metabolism [31, 32] and angiogenesis [33–35].
Embigin (EMB) and angiopoietin 1 (ANGPT1) were
downregulated candidate genes with the MF binding.
The gene product of EMB is a transmembrane glycoprotein required for the localization and function of MCT2,
a plasma membrane transporter of pyruvate, lactate, and
ketone bodies [36]. The downregulation of EMB in high
PE placentas suggests a lack of transport of these substrates, but given that pyruvate and lactate are gluconeogenic precursors and FBP2, encoding a gluconeogenic
enzyme, was upregulated, it is plausible that these substrates may be metabolized to produce glucose in high
PE placentas. On the other hand, ANGPT1 belongs to a
family of endothelial growth factors and is a glycoprotein
that inhibits endothelial permeability [37]. Thus, the
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downregulation of ANGPT1 in high PE compared to low
PE placentas indicates vascular permeability may be increased in high PE placentas.
Transporter activity was another MF of the DEG, with
a greater percentage of upregulated than downregulated
genes involved in transporter activity. The following are
candidate genes for PE with transporter activity: solute
carrier family 45 member 3 (SLC45A3), acid sensing ion
channel subunit 1 (ASIC1), solute carrier family 4 member 7 (SLC4A7), and solute carrier family 23 member 2
(SLC23A2). The gene SLC45A3 encodes for a novel H+
sucrose symporter, suggested to also transport fructose
and glucose [38, 39]. Verification of this function in the
pig placenta is required, but it appears sugar transport is
increased in high PE placentas. Acid sensing ion channel
1 isoform X2 (ASIC1) encodes for a proton-gated sodium ion channel that localizes to the plasma membrane
and golgi apparatus. Expression is most common in neurons [40] and to the authors’ knowledge has not been reported in the pig placenta. Assuming a similar MF,
upregulation of ASIC1 in high PE placentas indicates sodium ion transmembrane transport differs based on PE.
The gene SLC4A7 encodes for a sodium bicarbonate
(Na+: HCO3−) cotransporter [41] and the gene SLC23A2
encodes for a sodium dependent ascorbate (vitamin C)
co-transporter (2Na+: ascorbate) [42]. In rodent models,
both transporters have been implemented in the control
of vasodilation [41, 43]. Thus, the upregulation of these
transporters in high PE placentas may alter placental
vascular tone, but further research is required to elucidate the role of these transporters in the pig placenta.
Transporter activity was also a function of downregulated genes, like multidrug resistance associated protein 4
(MRP4) and potassium channel inwardly rectifying subfamily J member 2 (KCNJ2). The gene MRP4 encodes for
an active transporter protein with a broad substrate specificity [44]. Interpretation of the significance of MRP4
downregulation in high PE placentas requires further research into the substrates of MRP4 in the pig placenta.
The gene KCNJ2 encodes the inwardly rectifying potassium channel KIR2.1. Expression of KIR2.1 has been reported in the human placenta, but the tissue specific
function is unknown [45, 46]. Disruption of the potassium
channel in mice indicated KIR2.1 mediates vasodilation
[47]. The downregulation of KCNJ2 in high PE placentas
suggest potassium transport and potentially vasodilation
may be altered by PE.
Interestingly, two MF terms, molecular function
regulator and transcription regulator activity, were
functions of mostly downregulated genes. Molecular
function regulators modulate a gene products activity
and are often enzyme regulators or channel regulators
[48]. Downregulated genes associated with this term
were mostly enzyme regulators modulating intracellular
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activity. Transcription regulator activity describes the
function of controlling gene expression at the level of
transcription [48]. Accordingly, downregulated genes
with this function encoded for transcription factors.
Thus, downregulated genes were involved in the control of gene expression and the activity of gene products, which is not surprising given that this study
compares high PE to low PE placentas.
Functional classification of the DEG also identified BP
associated with the phenotype. Metabolic process, biological regulation, and localization had the greatest representation among the DEG. The gene products of more
upregulated than downregulated genes were involved in
metabolic processes. This is as expected given the MF
catalytic activity and transporter activity had the greatest
representation among the upregulated genes, and these
functions are often involved in metabolism. For instance,
CYP4F22 encodes for an ultra-long chain fatty acid
omega hydroxylase, an enzyme of fatty acid metabolism
[21]. Similarly, the genes FBP2 and SLC45A3 encode for
a gluconeogenic enzyme [22] and sucrose transporter
[38, 39], respectively, both of which are involved in
carbohydrate metabolism. Furthermore, the identification of metabolic processes as the BP with the greatest
representation in the DEG indicates extremes of PE are
related to metabolism.
Biological regulation was also a BP term of a large percentage of the DEG and is a broad term encompassing
genes products that modulate part of a BP [48]. More
downregulated than upregulated genes were involved in
biological regulation. Biological regulation was a term of
anterior gradient protein 2 (AGR2), the most downregulated gene in high PE compared to low PE placentas.
The gene AGR2 encodes for a member of the protein disulfide isomerase family of endoplasmic reticulum proteins, which are essential to post-translational folding
[49]. The protein has been implemented in epithelial
barrier function and cell proliferation. Moreover, it has
been suggested that AGR2 downregulation in sheep placentomes may serve as an adaptive placental mechanism
to support fetal growth during stress by reducing the
proliferative actions of AGR2 [50]. Whether AGR2 regulates a similar BP in the pig placenta remains to be determined. Other downregulated genes involved in
biological regulation included ANGPT1, a regulator of
vascular permeability [37], and several other genes encoding transcription factors.
While there were more downregulated genes involved
in biological regulation, a significant percentage of upregulated genes were also biological regulators. Among
these were probable cation-transporting ATPase 13A3
(ATP13A3) and solute carrier family 52 member 3
(SLC52A3). The gene ATP13A3 encodes a protein involved in calcium ion transmembrane transport, with
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evidence of polyamine transport in worms [51] and
humans [52]. Polyamines perform numerous essential
functions in mammalian physiology and are known regulators of placental growth and angiogenesis [53]. Thus,
ATP13A3 may be a candidate gene for high PE, but additional research into the substrate specificity of ATP13A3
in the pig placenta is required. The gene SLC52A3 also
encodes for a transporter, but with riboflavin (vitamin
B2) specificity. Riboflavin is a regulator of metabolism
via the active forms flavin mononucleotide and flavin adenine dinucleotide. Knockout of Slc52a3 in mice caused
reduced riboflavin concentrations in pups resulting in
death, with signs of hyperlipidemia and hypoglycemia
[54]. Thus, the upregulation of SLC52A3 in high PE placentas likely regulates metabolism. Overall, the large
percentage of DEG involved in biological regulation suggests extremes of PE may originate from differential
regulation of several BP.
Localization was also a BP term of a large percentage
of the DEG, with greater representation in upregulated
than downregulated genes. The term describes the
transportation or maintenance of a substance to a location [48]. The percentage of DEG involved in
localization is reflective of the MF with greatest representation among the DEG (catalytic activity, binding,
and transporter activity). For example, ASIC1 and
SLC23A2 were upregulated and encode for a sodium
ion transmembrane transporter [40] and an ascorbate
transmembrane co-transporter [42], respectively. Similarly, the downregulated genes STEAP1 and STEAP2
encode for transmembrane proteins with metal reductase and superoxide synthase activity [25, 26]. Furthermore, the DEG involved in localization indicate
micronutrient transport differs in extremes of PE.
The terms developmental process and biological adhesion were BP of mainly downregulated genes. The term
developmental process describes BP involved in the progression of a living unit [48]. Downregulated genes with
this BP mostly encoded transcription factors, suggesting
extremes of PE are driven by differences in the control
of development. Conversely, biological adhesion was a
term of downregulated genes involved in cell adhesion.
Among these were EMB and ANGPT1, encoding a
transmembrane protein that localizes monocarboxylate
transporters to the cell membrane [36] and an endothelial growth factor known to inhibit endothelial permeability [37], respectively. Thus, downregulated genes
involved in biological adhesion may affect the nutrient
transport capacity of high PE placentas.
A GO enrichment analysis was also performed on the
DEG in high PE compared to low PE placentas. Only 4
enriched terms were identified, which was probably due to
the limited number of DEG in the input list. The MF
terms sodium-dependent multivitamin transmembrane
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transporter activity and nucleobase transmembrane transporter activity, and the BP term nucleobase transport were
enriched, indicating vitamin transport and/or the transport of nitrogenous bases from one side of the membrane
to the other are imperative to high PE. The enrichment of
these terms also identified SLC23A2, mentioned previously, as a candidate gene for high PE. The fourth
enriched term was the cellular component term extracellular exosome, which describes gene products that localize
to vesicles that are released from cells into the extracellular region via exocytosis [48]. Exosomes are involved in
cell to cell communication and modulate intercellular
communication at the maternal-fetal interface in pigs [55].
Therefore, the enrichment of this term suggests exosomes
play a role in the cell to cell communication required for
the increased efficiency of high PE placentas. Additionally,
extracellular exosome was a term of 20 upregulated genes
in high PE compared to low PE placentas, validating the
association with high PE.
Fetal/utero-placental measurements and differentially
expressed genes

The correlation analysis performed between fetal/utero-placental measures and the DEG identified significant correlations between 8 of the DEG and placental weight or
PE. GRINL1A complex locus 1 (GCOM1), gene 19,656
(LOC100739517), ATP-binding cassette sub-family G
member 2 (ABCG2), and TOX high mobility group box
family member 3 (TOX3) were positively correlated with
placental weight and downregulated in high PE compared
to low PE placentas. The MF of GCOM1 in pigs is unknown. The gene ABCG2 encodes for an active transporter that is expressed in the human placenta and
transports xenobiotic compounds [56, 57]. Cholesterol activity was also a GO term of ABCG2. The protein product
of TOX3 may be involved in chromatin remodeling, and
the bending and unwinding of DNA [57]. Molecular function GO terms included chromatin binding, phosphoprotein binding, protein homodimerization activity, and
estrogen response element binding. Conversely, ras-related
protein rab-6B (RAB6B) was negatively correlated with placental weight and was upregulated in high PE compared to
low PE placentas. Molecular function GO terms of RAB6B
included GTP binding, GTPase activity, and myosin v binding. The protein encoded by RAB6B localizes to the
golgi apparatus and may function in retrograde membrane traffic [58]. Although the function(s) of these
genes within the pig placenta are largely unknown, the
identification of strong correlations with placental
weight, in combination with gene expression, indicates
GCOM1, ABCG2, TOX3, and RAB6B may regulate the
reduced placental size of high PE placentas.
Gene 12188 (LOC100156118), transmembrane protein
199 (TMEM199), and proto-cadherin beta 1 (PCDHB1)
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were positively correlated with PE and upregulated in
high PE compared to low PE placentas. Gene 12188 encodes an uncharacterized protein in swine. The MF of
TMEM199 in pigs in unknown, but the protein encoded
by this gene in humans may be involved in golgi homeostasis [57]. The gene PCDHB1 was among the 10 most
upregulated genes. The specific function of PCDHB1 is
unknown, but PCDHB1 may be a calcium dependent
cell to cell adhesion protein [57]. Given the strong positive correlations of gene 12188, TMEM199, and
PCDHB1 with PE, further research is warranted to determine the specific functions these genes may have
within the pig placenta.

however, further research is required to effectively incorporate PE into selection schemes. Identifying associations
between the phenotype and genome may be useful. Additionally, a limitation of this study was the method used to
define high and low PE. Using the highest and lowest PE
value within a litter is both advantageous and restrictive as
it ensures comparisons are only between the very most and
least efficient units, but excludes feto-placental units with
efficiencies that are closer to the average. Therefore, it is
suggested that future research determine the most appropriate method of defining high and low PE. Lastly, the role
extracellular exosomes play in PE and the impact of environmental effects on PE is also of interest.

Conclusion
Placental efficiency, quantified by the ratio of fetal
weight to placental weight, was determined within maternal line gilt litters to compare expression profiles of
high PE feto-placental units to low PE feto-placental
units. Mean fetal weight was not significantly different
between the high PE group and low PE group, but placental weight was significantly reduced in in the high PE
group, verifying comparisons were of similarly sized pigs
grown on different sized placentas. Likewise, the absence
of significant differences in fetal measures indicated any
negative effects of a reduced placental size on fetal
growth were not evident by day 95 of gestation. The
comparison of gene expression profiles in the placenta
and adjacent endometrium of high PE and low PE
feto-placental units identified 214 DEG in the placenta
and no DEG in the endometrium, confirming that the
placenta responds to the fetus.
Gene ontology functional classification analysis of the
103 upregulated and 111 downregulated genes identified
common MF and BP. The MF with the greatest representation among the DEG were catalytic activity, binding, and transporter activity. The BP with the greatest
representation among the DEG were metabolism, biological regulation, and localization. Further investigation
into the candidate genes associated with these terms
partially supported the hypothesis and suggested extremes of PE are differentially regulated, affecting components of placental transport capacity like nutrient
transport and blood flow. Conversely, DEG with growth
factor activity were minimal and alternative functions
were identified, indicating the complexity of the relationship between placental and fetal weights.
Overall, the results of this study support the use of PE
as a marker of placental function and provide new insights
into compensatory mechanisms that enable comparable
fetal growth despite a reduced placental size. In swine, PE
may provide an opportunity to optimize reproductive performance by normalizing the reduced birth weights of larger litters and in turn increasing pre-weaning survival;

Methods
Animal management

All procedures were approved by the West Virginia University Animal Care and Use Committee (WVU-ACUC;
ACUC # 10–0505). Eight Camborough 23 gilts (experimental unit; N = 8), owned by the WVU Animal Science
Farm (Morgantown, WV), were group housed in a hoop
structure equipped with tunnel ventilation and inspected
annually by WVU-ACUC. Gilts were monitored for estrous behavior beginning at 5 months of age. The first
estrus was observed and recorded. Gilts were bred by
artificial insemination 12 and 24 h after the onset of a
second estrus (6–7 months of age) using Pig Improvement Company (PIC) 1025 pooled maternal line semen
(Birchwood Genetics, West Manchester, OH). Assignments for gestational day 95 ovario-hysterectomies
(113–114 average day of farrowing) were randomly
assigned at the time of breeding. Following breeding,
gilts remained in this structure and were group housed
throughout gestation.
Surgical procedure

At least 2 days before surgery, gilts were moved to the Food
Animal Research Facility at the WVU Animal Science
Farm. Gilts were taken off of feed 12 h before surgery. On
the morning of the day of surgery, gilts (205.63 ± 37.6 kg)
were anesthetized via jugular venipuncture using ketamine
(3 mg/kg) and xylazine (2 mg/kg). Atropine sulfate (0.05
mg/kg) was administered to reduce salivation and isoflurane was used to maintain anesthesia.
Gilts were placed in dorsal recumbency and a midventral incision was made to expose the gravid uterus.
An antimesometrial incision was then made to open
the uterus and expose the feto-placental units. Two
tags were attached to the umbilical cord of each
feto-placental unit, identifying which uterine horn the
fetus (observational unit) originated from and the location within that uterine horn. The umbilical cord
was cut between the two tags to ensure a tag
remained with the placenta and the fetus. All fetuses
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were removed, and then the uterus was removed from
the dam and set aside for processing. Sodium pentobarbital (400 mg/mL, Sigma Aldrich, St. Louis, MO)
was used to euthanize the gilt.
Fetal and utero-placental measurements

Fetal weight, CRL, and girth were recorded as fetuses
were removed from the uterus. Fetal necropsies were
performed to obtain heart weight, liver weight, brain
weight, and left hindquarter ST weight. The uterus was
opened along the antimesometrial side and laid flat.
Boundaries of each placenta were identified and a sample (~ 6.5 cm2) of all tissue layers (placenta, endometrium, and myometrium) was collected from an area void
of calcium deposits and representative of the entire placenta. Samples were placed in tissue cassettes and fixed
in neutral buffered formalin for histological processing.
Then each placenta was peeled away from the endometrium and weighed. At this time representative samples,
as described by Krombeen and others [5], were taken
from both the placenta and the adjacent endometrium,
placed in 2.0 mL cryovials (filled to 1.8 mL), and snap
frozen in liquid nitrogen for RNA extraction. Implantation site length for each placenta was measured in the
empty uterus using avascular bands as boundaries. Placental efficiency was determined for each feto-placental
unit by dividing fetal weight by placental weight.
Similar to Krombeen and others [5], tissue cross sections containing placenta, endometrium, and myometrium
were fixed in formalin, dehydrated with graded ethanol
and xylenes, perfused with molten paraffin, and embedded
in paraffin molds. Five micrometer sections were fixed to
glass slides. Two sections for each fetus were stained using
periodic acid and Schiff’s reagent (Sigma Aldrich, St.
Louis, MO). Along the placental-endometrial interface,
two fields per section were visualized (Nikon Eclipse
TE2000–5, Nikon Instruments Inc., Melville, NY) and
captured (Retiga 2000R, Q Imaging, Surrey, BC, Canada;
Q Capture, Quantitative Imaging Corporation, v2.90.1,
Surrey, BC, Canada) for a total of four fields visualized.
Northern eclipse v6.0 software (Empix Inc., North Tonawanda, NY) was used to analyze images. Placental and
endometrial tissues were outlined separately, and then
total number of vessels, total area of vessels, and total area
selected were measured. Vascular density was determined
by dividing the area of the vessels by the total area selected. Replicates were averaged.
To compare fetal and utero-placental measurements
of high PE and low PE units, the feto-placental unit with
the highest PE and the feto-placental unit with the lowest PE in each litter (n = 8) were selected, creating the
high PE group (n = 8, PE range 3.96 to 7.84) and the low
PE group (n = 8, PE range 1.92 to 3.19) used for analysis.
Statistical analyses were conducted using JMP Pro
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version 12.2.0 (SAS Institute Inc., Cary, NC 1989–2007).
A linear mixed effects model was used to analyze each
dependent variable (placental wt, fetal wt, ISL, CRL,
girth, heart wt, liver wt, brain wt, ST wt, placental VD,
and endometrial VD), with PE, sex, and PE*sex as fixed
effects, and a random effect to account for pigs nested
within dam. A significance level of 0.05 was used for all
statistical tests.
Differential gene expression and gene ontology

Endometrial and placental samples from the most efficient (2 female, 6 male) and least efficient (3 female, 5
male) feto-placental unit in each litter (n = 8) were processed at the Clemson University Genomics & Computational Laboratory (CU-GCL). Total RNA was extracted
from the endometrial (n = 16) and placental (n = 16)
samples in duplicate using a RNeasy Plus Universal Mini
Kit (Qiagen, Valencia, CA) and all extractions were performed according to the manufacturer’s instructions. An
aliquot of each sample was qualitatively assayed for purity using UV spectroscopy via the Nanodrop8000 (ThermoFisher Scientific, Waltham, MA) to determine the
260/280 and 260/230 ratios, respectively. RNA integrity
was measured using an Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). All RNA purity ratios, were > 1.8 and all RNA integrity numbers
(RIN) were approximately 6. Total RNA was quantitated
with the Broad Range Assay in the Qubit (ThermoFisher
Scientific, Waltham, MA).
Each sample was normalized to a standard input concentration of 2 μg for sequencing library preparation.
Stranded mRNA sequencing libraries were prepared
manually at the CU-GCL with the TruSeq Stranded
mRNA kit (Illumina, San Diego, CA) following the manufacturer’s recommended procedures. Sequencing data was
collected on the HiSeq2500 (Illumina, San Diego, CA)
using v4.0 chemistry and 2x125bp paired-end reads. Post
sequencing, raw sequence reads were transferred to Clemson University’s Palmetto Cluster for analysis.
Sequence reads were quality validated with the FastQC
software [59], followed by read preprocessing to remove
adapter and primer sequences with the Trimmomatic
software [60]. Processed sequence reads were aligned to
the v10.2 Sus Scrofus reference genome assembly [61]
with the GSNAP read alignment tool [62]. Sorted and
indexed. BAM files were prepared from the. SAM output of GSNAP using Samtools [63]. Uniquely mapped
read abundance per gene was determined with the featureCounts software in reversely stranded mode [64],
and the count data per sample was output and transformed to tabular format.
Relative pairwise changes in gene level expression were
determined with the edgeR software package [65]. Transcriptome comparisons were made using a generalized
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linear model and pairwise comparisons were made to
compare low efficiency versus high efficiency conditions
in a tissue specific manner. Differentially expressed
genes were determined and filtered for significance using
the FDR of 0.10 [66, 67]. Gene level fold-change values
were output in tabular format and genes abounding
thresholds were listed as candidate genes.
Candidate gene lists containing upregulated and downregulated genes in the placenta were functionally classified
using the Panther database version 14.0 [68, 69] and
AmiGO 2 version 2.5.12 was utilized to search GO term
definitions [48, 70, 71]. Hierarchical functional classification was used to categorize genes according to the activity
of the gene product (molecular function) and the pathway
or processes the gene product functions in (biological
process) [70, 71]. Gene ontology slim terms were utilized
to classify gene lists according to defined terms. Percentages equal the number of genes within the input list with
that MF or BP divided by the total number of MF or BP
in the input list (gene hits against total number of function
hits or gene hits against total number of process hits).
Candidate gene lists containing upregulated and downregulated genes in the placenta were also independently
tested for statistical enrichment (FDR < 0.05) with the
GOSeq software tool [72].
The subset of candidate genes listed in Table 2 were
associated with the MF and BP with the greatest representation in the DEG and were selected based on log2FC
(10 most upregulated or downregulated genes) and/or
GO terms related to nutrient transport, angiogenic activity, or growth factor activity.

protein; GLA: Alpha-galactosidase A; GO: Gene ontology; HSPE1: 10 KDa
heat shock protein mitochondrial; ISL: Implantation site length;
ITIH3: Inter-alpha-trypsin inhibitor heavy chain H3; IUGR: Intrauterine
growth restriction; KCNJ2: Potassium channel inwardly rectifying
subfamily J member 2; KRTAP8–1: Keratin associated protein 8–1;
LEP: Leptin; LOC102159690: Solute carrier family 23 member 2-like;
log2FC: Log2 fold change; MCOLN3: Mucolipin 3 isoform X2;
MGST3: Microsomal glutathione S-transferase 3; MORN5: Morn repeat containing
protein 5 isoform X8; MRP4 or ABCC4: Multidrug resistance-associated protein
4-like; PCDHB1: Protocadherin beta-1 isoform X2; PDHB: Pyruvate
dehydrogenase E1 component subunit beta; PE: Placental efficiency;
PEBP: Phosphatidylethanolamine-binding protein 1; PI16: Peptidase
inhibitor 16 precursor; PIC: Pig improvement company; PPA1: Inorganic
pyrophosphatase; PW: Placental weight; RAB6B: Ras-related protein
rab-6b; RIN: Rna integrity number; RPL15: Ribosomal protein L15;
SAA2: Serum amyloid A2; SARDH: Sarcosine dehydrogenase;
SLC23A2: Solute carrier family 23 member 2; SLC45A3: Solute carrier
family 45 member 3; SLC4A7: Solute carrier family 4 member 7;
SLC52A3: Solute carrier family 52 member 3; SLITRK5: SLIT and NTRK-like
protein 5; SPHKAP: Sphingosine kinase type 1; ST: Semitendinosus;
STEAP1: Six-transmembrane epithelial antigen of prostate 1; STEAP2: Six
transmembrane epithelial antigen of the prostate 2;
TMEM199: Transmembrane protein 199; TMEM72: Transmembrane protein
72-like isoform X2; TOX3: Tox high mobility group box family member 3;
TXN: Thioredoxin; TXNDC8: Thioredoxin domain-containing protein 8;
VD: Vascular density; WVU: West virginia university
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